7. Net Income (Loss) per Common Share (Tables)

9 Months Ended

Jan. 31, 2021

Earnings Per Share [Abstract]

Reconciliation of earnings per share

A reconciliation of the numerators and the denominators of the basic and dilutive net income (loss) per common share computations for the three and nine months ended January 31, 2021 and 2020, are as follows (in thousands, expect per share amounts):

	Three Months Ended January 31,						Nine Months Ended January 31,
	2021			2020			2021			2020
Numerator
Net income (loss)	$	2,207		$	(2,104	)	$	9,221		$	(5,698	)
Series E preferred stock accumulated dividends		(1,442	)		(1,442	)		(3,604	)		(3,604	)
Net income (loss) attributable to common stockholders	$	765		$	(3,546	)	$	5,617		$	(9,302	)
Denominator
Weighted average common shares outstanding, basic		58,865			56,404			57,349			56,275
Effect of dilutive securities:
Stock options		937			–			507			–
RSUs		279			–			188			–
ESPP		16			–			14			–
Weighted average common shares outstanding, dilutive		60,097			56,404			58,058			56,275
Net income (loss) per share, basic	$	0.01		$	(0.06	)	$	0.10		$	(0.17	)
Net income (loss) per share, diluted	$	0.01		$	(0.06	)	$	0.10		$	(0.17	)

Schedule of antidilutive shares

The following table presents the securities excluded from the calculation of diluted net income (loss) per share for the three and nine months ended January 31, 2021 and 2020, as the effect of their inclusion would have been anti-dilutive (in thousands):

	Three Months Ended January 31,				Nine Months Ended January 31,
	2021		2020		2021		2020
Stock options		325		2,106		1,665		2,721
RSUs		–		–		4		8
ESPP		–		–		2		–
Series E Preferred Stock		1,979		1,979		1,979		1,979
Total		2,304		4,085		3,650		4,708